Impaired fasting glucose and the prevalence and severity of angiographic coronary artery disease in high-risk Chinese patients

Metabolism: Clinical and Experimental

Volumn 57, Issue 1, 2008, Pages 24-29

  Dong, Xuehong ^a   Zhou, Linuo ^a   Zhai, Yingjiu ^a   Lu, Bin ^a   Wang, Dong ^a   Shi, Haiming ^a   Luo, Xinping ^a   Fan, Weihu ^a   Hu, Renming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHINESE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; CHINA; CORONARY DISEASE; FASTING; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERTENSION; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 36849080885     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.08.004     Document Type: Article

References (26)

1. Davidson M.B. Counterpoint: the oral glucose tolerance test is superfluous. Diabetes Care 25 (2002) 1883-1885
2. Genuth S., Alberti K.G., Bennett P., et al. Expert committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
3. Forouhi N.G., Balkau B., Borch-Johnsen K., et al., On behalf of EDEG. The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. Diabetologia 49 (2006) 822-827
4. Stern M.P., Fatehi P., Williams K., et al. Predicting future cardiovascular disease: do we need the oral glucose tolerance test?. Diabetes Care 25 (2002) 1851-1856
5. Qiao Q., Jousilahti P., Eriksson J., et al. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 26 (2003) 2910-2914
6. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342 (2000) 381-389
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
8. Gu D., Reynolds K., Duan X., et al., InterASIA Collaborative Group. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 46 (2003) 1190-1198
9. Solymoss B.C., Bourassa M.G., Campeau L., et al. Incidence, coronary risk profile and angiographic characteristics of prediabetic and diabetic patients in a population with ischemic heart disease. Can J Cardiol 19 (2003) 1155-1160
10. Kukreja N., Wilkinson J.R., MacDuff A., et al. Under-diagnosis of diabetes mellitus in patients with coronary artery disease. Int J Cardiol 97 (2004) 77-82
11. Drexel H., Amann F.W., Beran J., et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 90 (1994) 2230-2235
12. Austen W.G., Edwards J.E., Frye R.L., et al. American Heart Association report: a reporting system in patients evaluated for coronary artery disease. Circulation 51 Suppl 4 (1975) 5-40
13. Haffner S.M., Lehto S., Ronnemaa T., et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
14. Coutinho M., Gerstein H.C., Wang Y., et al. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
15. DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care 26 (2003) 688-696
16. Wen C.P., Cheng T.Y., Tsai S.P., et al. Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care 28 (2005) 2756-2761
17. Levitan E.B., Song Y., Ford E.S., et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164 (2004) 2147-2155
18. Kanaya A.M., Herrington D., Vittinghoff E., et al. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease. Ann Intern Med 142 (2005) 813-820
19. Badak O., Schoenhagen P., Tsunoda T., et al. Characteristics of atherosclerotic plaque distribution in coronary artery bifurcations: an intravascular ultrasound analysis. Coron Artery Dis 14 (2003) 309-316
20. Wascher T.C., Sourij H., Roth M., et al. Prevalence of pathological glucose metabolism in patients undergoing elective coronary angiography. Atherosclerosis 176 (2004) 419-421
21. Satoh H., Terada H., Uehara A., et al. Post-challenge hyperinsulinaemia rather than hyperglycaemia is associated with the severity of coronary artery disease in patients without a previous diagnosis of diabetes mellitus. Heart 91 (2005) 731-736
22. Nakagami T., and DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47 (2004) 385-394
23. The DECODE Study Group, and The European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161 (2001) 397-405
24. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 27 Suppl 1 (2004) S11-S14
25. Mooy J.M., Gootenhuis P.A., de Vries H., et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in general Caucasian population: the Hoorn Study. Diabetologia 39 (1996) 298-305
26. Ko G.T., Chan J.C., Woo J., et al. Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population. Diabetes Care 21 (1998) 2094-2097